Overview of Recent Advances in Nano-Based Ocular Drug Delivery
International Journal of Molecular Sciences · 3 authors, 1 centre
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The review discusses FDA-approved nano-based ophthalmic formulations, including Cequa® (cyclosporine A 0.09% nanomicellar solution) for dry eye disease.
Full summary
207 CHARS
The review discusses FDA-approved nano-based ophthalmic formulations, including Cequa® (cyclosporine A 0.09% nanomicellar solution) for dry eye disease. The review does not report original experimental data.